Equidae Flashcards

1
Q

What order and family are horses in?

Describe the conservation status of these animals.

What are the scientific names of the following animals:
- Przewalski’s Horse
- African Wild Ass
- Asiatic Wild Ass (Kulan, Onanger)
- Kiang
- Cape Mountain Zebra
- Hartmann Mountain Zebra
- Grevy Zebra
- Plain’s Zebra

A
  • General biology:
    • Order Perissodactyla (Equidae, tapiridae, rhinocerotidae).
      • Distinguished from the family artiodactyla by their foot morphology and digestive system.
    • Equidae: Horses, wild asses, zebras.
      • IUCN Equid Specialist Group lists 7 species, numerous subspecies under the Equus genus.
      • Most spp at risk of extinction.
        • Once widespread in grassland and desert habitats through NA, asia, Africa, Europe. Currently eastern and southern Africa, regions of asia.
      • Modern equids live in harsh, dry lands/grasslands shared by nomadic peoples.
        • Generally polygynous, highly social.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the unique anatomy of nondomestic equids.

How do their coats differ?

What is their general dental formula? What type of cheek teeth do they have?

Do they have a gallbladder?

How does nondomestic equid foot anatomy differ from domestic horses?

A
  • Unique anatomy:
    • Similar to domestic horse internally, distinguish by external appearance.
      • Przewalski horse most noted for horse-like appearance.
      • Asian and wild asses - solid and subtle color patterns on body and legs.
      • Zebra species - distinct striping patterns, differentiate species and individuals.
    • Internal anatomy.
      • Bulk-feeding herbivores.
      • Dental formula: I3/3, C1/1, PM 3-4/3, M 3/3 total 40-42 teeth.
      • Canines vestigial or absent in females.
      • Hypsodont cheek teeth.
    • GI designed for hindgut fiber fermentation.
      • Small stomach, large cecum and colon. All perissodactyls lack a GB.
      • Foot posture is unguligrade (bearing weight on one functional digit).
        • Third digit is well formed and only weight bearing digit in equidae.
        • Minor differences in foot anatomy.
          • In general, domestic equids have larger feet with a greater frog:sole ratio vs nondomestic equids.
          • Radius and ulna, fibula and tibia are fused.
          • Nondomestic horses have smaller feet.
          • Przewalski horse hoof is most similar to domestic horse.
          • Grevy’s zebra similar to mule or donkey, narrow, more upright.
            • Frog to sole ratio is less.
          • Mountain zebras have a smaller foot, otherwise similar.
          • African wild asses feet are similar to zebras, Asian wild asses more robust structure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the ideal housing for equids.

What enrironmental and safety considerations need to be considered?

A
  • Special housing requirements:
    • Generally hardy, withstand normal to severe temp variations as long as shelter and wind/sun protection is available.
    • Gravy zebras are reported to be less cold tolerant.
    • Proper food storage, access to fresh water.
    • Periodic hoof trimming in some species (mountain zebras and Przewalski horses seem to need more frequent trims, q6-9 months).
    • May be violent and aggressive with each other. Infanticide well documented.
    • Careful when introducing a male to a new herd or pregnant female to new stallion.
      • Stallions aggressive toward new foals and keepers.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the ideal nutrition for equids.

Are they browsers or grazers?

What issues may occur with feeding alfalfa?

What are some common nutritional issues?

A
  • Feeding:
    • All are bulk feeding grazers, primarily feed on grass and roughage.
      • Wild – 90% grass zebra diet.
      • Reportedly eat some browse in wild.
      • In general, nondomestic equids have no specialized feeding requirements and may be fed like domestic equines.
      • High fiber pellets and grass hay combination recommended.
    • In regions where enteroliths are a problem, reducing or eliminating alfalfa in the pellet or hay source is recommended.
    • Pellet and hay may be fed at ratio of 50% pellet, 50% hay.
      • Intake should be 1.5-3% BW.
      • Salt and trace mineral blocks may be used if pellet diet cannot be specially formulated.
      • Produce is not recommended. Can use for behavioral training or enrichment.
        • No more than 2-5% of the diet on a DM basis.
    • Obesity may be a problem in zoos. Encourage exercise, restrict pelleted feed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe a preventative medicine protocol for equids.

A
  • Preventive medicine:
    • Preshipment testing recommended for any relocation.
      • Including zoo or free ranging transfers such as reintroduction, translocation, relocation from one institution or field site to another.
        • Fecal sample for parasites.
        • Fecal culture.
        • Blood for CBC, chemistry, serum archive.
        • Vaccination if indicated regionally i.e. tetanus toxoid, rabies.
        • PE.
        • Oral and hoof inspections and hoof trims.
        • Quarantine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the restraint of nondomestic equids.

What physical methods can be used? What risks are there to this approach?

What oral sedatives are available?

Describe the diferences in duration and onset of the following neuroleptics: Haloperidol, Zuclopenthixol, Perphenazine.

What drugs are commonly used for immobilization? What ultrapotents do not work in equids?

Describe ideal dart placement for equids.

Describe the monitoring and management of anesthetized equids (intubation, ventilation, monitoring equipment).

A
  • Restraint and handling:
    • Hydraulic hugger restraint chutes +/- chemical restraint.
      • Startle easily, may bolt into solid obstacles -> fatal head and neck injuries.
    • Chemical restraint.
      • Acepromazine granules and oral haloperidol effective for oral sedation to aid in transport or acclimation to new housing.
      • Injectable short acting sedatives such as xylazine, acepromazine, and butorphanol may be used.
      • Long acting neuroleptic sedatives may be used, sometimes in combo to achieve desired length of sedation.
        • Haloperidol is short acting, relatively rapid onset of 5-10 minutes. Duration 8-18 hours.
        • Zuclopenthixol medium acting. Onset in 1 hour, duration 3-4 days.
        • Perphenazine is a long acting. Onset in 12-16 hours and duration of 10 days.
        • May occasionally cause extrapyramidal signs i.e. hyperexcitability and incoordination.
      • Full immobilization.
        • Opiod narcotics.
        • Etorphine is most commonly used.
          • Often in combination with alpha 2 agonists, ketamine, phenothiazine tranq, or combination.
        • Carfentanil has also been used with the Przewalski horse and Hartmann mountain zebras.
          • Less consistent, more unpredictable in onagers, kiangs, and somali wild asses.
          • Largely ineffective and not a good choice for Grevy zebras.
        • Thiafentanil shows promise.
      • Opioids generally cause significant muscle rigidity.
        • When used alone, animals will often not become recumbent. May require casting.
        • May be avoided by using alpha2 agonists prior to or along with opiod.
        • Supplemental drugs i.e. guaifenesin or propofol may be used to provide relaxation.
      • Several other factors besides chemical agents to consider:
        • Obtain accurate body weight.
        • Work with experienced or trained support staff.
        • Precise dart placement.
        • Advantages or disadvantages of pre-anesthetic medications.
        • Prevalence of renarcotization in the species
        • Soft, appropriate area for recovery.
      • Regurgitation is not a risk, food and water should be withheld for 18-24 hours prior to procedure to reduce GI volume. Provide water if hot weather.
      • Darting.
        • Location ideal in a large muscle mass i.e. gluteals, shoulder, or neck.
        • Avoid areas of fat.
        • Blindfolds, earplugs.
        • Supplemental oxygen.
        • Anesthesia monitoring – HR, rhythm, rate and depth of ventilations, pulse ox.
      • For prolonged procedures, GA.
        • Isoflurane, mechanical ventilation.
        • Intermittent IV propofol to extend anesthesia.
        • Blind intubation, as in horses.
        • Indirect BP may be measured with an appropriate sized cuff around metacarpal or metatarsal area.
        • Arterial samples for blood gas from facial artery or IM branch of the caudal auricular artery.
        • EtCO2, direct art line for BP, ECG useful for prolonged anesthesia.
          • ECG parameters for gravy zebras have been described.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How many equine herpesviruses have been identified?

Which are gammaherpes? Which are alphaherpesviruses?

What are the clinical signs of both groups?

Which viruses lack species specificity?

A

Equine Herpesvirus Background:

  • Herpesviruses are generally host-specific.
    • Zoonotic infections are not of general concern.
    • However, some cross-species and cross-ordinal infections have been described and severe/fatal.
      • i.e. Malignant catarrhal fever (Gammaherpesvirinae) can cause outbreaks with high mortality in mixed-spp collections.
  • Equine herpesviruses cause interspecies infections.
  • Nine EHVs identified.
    • EHV2, EHV5, EHV 7 – Gammaherpesvirinae.
      • Most derived from bats and primates.
      • Rarely assoc. with dz, except MCF, Epstein-Barr, Kaposi sarcoma-associated herpesviruses.
    • EHV1, EHV3, EHV4, EHV6, EHV8, EHV 9 – Alphaherpesvirinae.
      • All associated with abortion, neonatal death, respiratory and neurologic disorders in domestic equids.
      • EHV1 – one of the most consequential, worldwide.
        • Recent discoveries in zoo and wildlife suggest EHV1 and close relative EHV9 lack strong spp specificity, can infect and cause dz in other mammals.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the diagnosis of equine herpesviral infections.

What are the typical clinical signs?

What tissues and samples should be collected?

What are the typical histologic lesions?

Discuss the benefits fo ELISA over antibody titers or serum neutralization.

A

Diagnostics:

  • Typical clinical signs:
    • Neurologic – seizures, encephalopathy (stroke-like syndrome) following endothelial cell infection and vasculitis. Myeloencephalopathy affecting the spinal cord in equids. In other spp, severe seizures
    • Abortion.
  • Fetal tissues should be frozen.
  • Nasal discharge/swabs, blood and serum should be collected from adults.
  • In fatal cases – lung, blood, serum, nasal epithelia, and brain tissue should be stored at -80C. Or refrigerate if can be transported to lab within few days.
    • Pathologic findings – nonsuppurative encephalitis and gliosis, Barr bodies mostly absent.
    • qPCR for pan-herpesvirus or more sensitive EHV-specific quantitative PCR assays.
  • Many will be asymptomatic and will clear infection.
    • Antibodies may persist long term or lifelong.
    • Serology-based approaches measure Ab vs virus or viral antigen.
      • Serum neutralization examines whether viral replication can be neutralized by serum of a given animal, indicating Ab are produced by the individual.
      • Will not discriminate between closely related viruses because they are antigenically similar.
      • Synthetic peptides designed to ID viral epitopes that are distinct are developed for EHV1, 4, and 9 (alphas) (ELISA).
        • Can perform on 96 samples in a single plate, allows screening of large number of individuals.
        • Peptide antigen coats the plates, then serum applied followed by secondary Ab.
          • When secondary Ab binds, initiates enzymatic reaction that can be detected.
        • Peptides for EHV1 cross react with EHV9 specific sera.
          • However, EHV9 peptide does not react with EHV1 positive sera.
          • Substantially more sensitive to low Ab titer vs SNT analysis.
          • Application of carnivore sera has not yet been successful, restricting analysis in these spp to SNT.
          • Both methods allow for determination of EHV 1 and EHV 9 exposure, whether individual is currently infected or not.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What taxa have been eperimentally infected with Equine Herpesvirus 1 (EHV1)? What clinical signs developed?

What taxa have been experimentally infected with EHV9? What signs developed in those animals?

A

Experimental Interspecies Infections:

  • Like gammaherpesviruses, EHV1 and EHV9 can infect non-equine spp.
    • Rabbits infected with EHV1 – resp and neuro signs.
    • Mice infected with EHV1 – clear lytic infection but establish latency, depending on EHV1 strain, others produced neuro signs.
    • Mice able to clear EHV9 after 72h.
      • Lesions induced in hamsters.
    • Dogs and cats – neuro signs with EHV9.
    • Goats – lethal encephalomyelitis EHV9.
    • Pigs – one study saw no CS although neuro lesions were observed, second experiment meningoencephalitis induced.
    • Primates – macaques resistant to EHV9, marmosets severe neuro signs.
  • EHV1 and EHV9 are able to infect and cause clinical signs in broad mammalian spp, including primates.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What interspecies transmission of equine herpesvirus has been documented in zoos?

What species were susceptible with EHV1? What about EHV9?

What clinical signs developed?

What perisodactyl species is more likely to be seropositive for EHV1 in the wild?

What perisodactyl species is more likely to be seropositive for EHV9 in the wild?

A

Nonexperimental Interspecies Infections;

  • Full susceptibility of species outside of laboratory setting largely unclear.
  • Infection in zoological collections and the wild.
    • Non-equid spp:
      • EHV9 fatal cases in captive Thompson’s gazelles, giraffes, and a polar bear
        • Does not appear to be naturally occurring in domestic horses.
      • Captive gazelles, antelopes, cattle, alpacas, llamas, and black bears have been infected with EHV1.
      • An EHV1 and EHV9 recombinant virus was associated with lethal and nonlethal polar bear encephalitis and with a fatal encephalitis in an Indian rhino.
    • Equid spp:
      • Isolated from zebras and other wild equine spp.
  • EHV1 and EHV9 also exhibit cross spp circulation in the wild.
    • Black and white rhinos seropositive for both.
    • Significant prevalence of EHV1 and 9 in captive and wild black rhino and plains zebra populations.
      • Captive zebras have a significantly lower prevalence of seropositivity than wild zebras.
      • Zebras in general more likely positive for EHV1 vs EHV9.
      • Rhinos more likely seropositive for EHV9 vs EHV1.
        • African rhinos may be reservoirs for EHV1 and EHV9.
        • Rhinos in captivity could result in cross spp transmission of either virus.
        • EHV1 and EHV9 have a broad host range and broad prevalence in perissodactyls.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is EHV transmitted?

What is the primary transmission between equids?

Cases of interspecies transmission has been what route?

How does EHV persist in the environment?

What role do wild animals or fomites play?

What about the feeding of equine meat?

A

Modes of Transmission:

  • EHV 1 and 9 spread as respiratory smear infection.
    • Applies to equids.
    • In majority of cross-spp transfers, no obviour physical contact between equids and other spp.
      • i.e. fatal EHV1 infection in polar bear, zebra enclosure was 200 m away. Keepers not shared between. Bears not fed equine meat.
    • Direct respiratory transmission from requid to non-equid has NOT been likely in MAJORITY of reported interspecies cases!
  • EHV1 has been shown to persist on surfaces such as stall bedding, shavings, and leather (fomites).
  • EHV1 remains stable for several weeks in water, even at high temps.
    • Possible rodents or birds that move among enclosures in zoos between water sources are exposing multiple enclosures.
    • Could also serve as fomites.
  • Mode of transmission from environmental sources or IM hosts remains an unsolved mystery.
  • Stringent hygiene controls should be applied to prevent spread from equid or rhino enclosures to other areas of the zoo.
  • Equid meat should only be fed to carnivores naturally sympatric with equids.
    • i.e. lions consume zebras in nature but polar bears do not.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What vaccines are available for equine herpesviruses?

What does the literature say about their efficacy?

What is the role of monitoring of viral shedding in preventing outbreaks and cross-species transmission?

A

To Vaccinate or Not?

  • Horses – commercial live viral vaccine (rhinoimmune) and two inactivated viral vaccines (Pneumabort K-Fort Dodge and Prodigy-Intervet).
    • Conflicting evidence for live vs inactivated vaccines lowering incidence of EHV1 induced abortions.
    • Majority of publications suggest efficacy.
    • Little evidence that vaccination can prevent neuro disease.
    • Does not guarantee complete prevention of viral shedding.
    • Consistent monitoring of viral shedding, isolation of shedding individuals, and decontamination of areas exposed to shedding animals will be key to managing cross-spp transmission.
      • If used regularly, monitoring for shedding can be detected early enough to isolate individual animals and prevent build-up of virus in the environment that would promote transfer.
      • Implementation of monitoring is strongly recommended.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are sarcoids?

What are they caused by?

Where are they typically seen in plain’s zebras? Wat about Somali wild asses?

What about wild Cape mountain zebras?

How are they definitively diagnosed?

A
  • Sarcoids.
    • Unencapsulated, poorly demarcated fibroblastic skin tumors.
    • Invade locally, may recur after surgery. Not metastatic.
    • Overlying epidermis is frequently hyperplastic.
    • Equine sarcoid are associated with bovine papilloma virus (BPV) type 1 and 2 infection.
      • Reported from sarcoids at the eyelid, nose and inguinal region in captive Burchell’s zebras.
      • Sarcoids at the ear, prepuce, and mammary gland in Somali wild asses are thought to be virus-associated.
      • Also reported in wild Cape mountain zebra, esp along ventral abdomen and legs, in two reserves in South Africa (53% prevalence).
      • Viral DNA has been detected in nuclei of the neoplastic mesenchymal cells of zebra sarcoids.
        • Late viral antigens are not found in sarcoids and neutralizing antibodies to the virus are not found in horses.
        • Suggests the infection is nonproductive in horses.
        • Mechanism of transmission of bovine papilloma virus to the zebras has not been identified.
        • Sarcoids do not produce virions.
          • Viral DNA and RNA may be detected.
          • BPV type 1 and 2 major transforming protein E5 is expressed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some important bacterial diseases of equids?

What conditions predispose animals to anthrax?

What are some clinical signs of salmonellosis in equids?

Strangles is caused by what etiologic agent? How has this affected p horse introductions?

A
  • Anthrax.
    • Threat to populations of free ranging Grevy zebras in Africa.
      • Both mature and immature animals.
      • Drought and other adverse environmental conditions predisposing factors.
      • Dry conditions may promote trauma in oral cavity, increases risk of acquiring anthrax spores.
        • Widespread vaccination has been used, efficacy has not yet been determined.
  • Salmonellosis – abortion and genital tract infection of equids.
  • Clostridial infections – C. welchii with wound infection and septicemia in Somali wild ass.
  • Strangles – suppurative lymphadenitis with streptococcus equi.
    • Associated with pharynx and resp tract.
    • Cluster of deaths in P horses reintroduced to SW Mongolia.
    • Association with harsh winter and wolf predation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe fungal disease in equids.

What species appears overly susceptible to coccidioidomycosis? How is this agent transmitted?

How did this impact zoo populations?

Describe phaeohyphomycosis infection in equids? What lesions occurred? What species has this been observed in?

A
  • Coccidioidomycosis has been reported in Przewalski horses in CA, where coccidioides immitus is endemic.
    • Usually asymptomatic, resolve spontaneously.
    • Transmission by inhalation of arthroconidia.
    • Immunosuppression increases risk of disseminated infection in humans and domestic animals.
    • Leading cause of death in a population of przewalski horses 1980-2000.
      • Disseminated granulomatous lesions/respiratory system.
        • More common in males and younger individuals.
        • Possibly due to intraspecific aggression and stress in bachelor herds.
        • Other species of equid at same facility not affected.
    • Management strategies that reduce stress may be helpful.
  • Phaeohyphomycosis.
    • Opportunistic, dematiaceous (pigmented) fungal infection caused by variety of fungal species.
    • Ubiquitous in soil and woody plants.
    • Systemic infection nis rare.
      • Vascular invasion infrequent, often associated with immunosuppression.
      • Infection originates in resp system after inhalation.
      • Cutaneous disease after wound infection.
      • Sudden onset weight loss, lethargy, hypothermia in captive male Grevy’s zebra.
      • Focal pyogranulomatous pneumonia, myocarditis, pericardial effusion associated with moniliform fungal hyphae.
      • Yeast forms found in heart.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the etiologic agents of piroplasmosis in equids?

Where are these diseases endemic?

How are they transmitted?

What clinical signs and lesions to they cause?

What role does translocation play in disease ecology?

What equid species have been affected?

A
  • Piroplasmosis (protozoal disease).
    • Possible cause of mortality in reintroduced Przewalski horses in Mongolia.
  • Babesia caballi and Theileria equi probably endemic throughout Asia.
    • Piroplasmosis.
    • Attack and destroy RBCs.
    • May occur seasonally with tick vector.
    • Translocation may induce dz by spreading pathogens, stress hormones influence immune system and allow proliferation of piroplasms in host.
    • Severe regenerative hemolytic anemia, jaundice in acute cases.
    • Chronic cases subclinical carriers.
    • Pulmonary edema, splenic congestion.
    • Renal tubular necrosis, disseminated hemosiderin-laden macrophages.
    • Transplacental infection may cause abortion.
      • Aborted fetuses have high levels of parasitemia.
    • P horses in Mongolia – piroplasmosis cause of death of stallions and a stillborn foal.
    • Somali wild ass – diagnose with babesiosis.
    • Cograzing donkeys and wild Grevy’s zebra in Kenya – all zebra tested positive for T. equi.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the etiologic agent of equine protozoal myeloencephalitis?

What is the definitive host of this organism?

What lesions have been seen as a result of this disease?

A
  • Equine protozoal myeloencephalitis.
    • Sarcocystic neurona.
    • Opossum Didelphis virginiana definitive host of sarcocystis falcatula and may be definitive host of S. neurona.
      • Captive Grant’s zebra acute ataxia, weakness, depression.
      • CSF positive for Ab to S. neurona on Western blot.
      • Perivascular cuffing with MN cells at brainstem.
      • S. neurona ID by IHC staining of merozoites.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are some common equid parasites?

Describe the effects of Halicephalobus gingivalis infestation in zebras?

Describe the life cycle and lesions associated with Kosiella equi?

A
  • GI parasites (parascaris equorum, strongylus, strongyloides, oxyuris).
  • Halicephalobus gingivalis – captive Grevy’s zebra.
    • Rhabditiform nematode.
    • Apparently blind and behaving abnormally.
    • Bilateral uveitis, anemia, increased globulins (beta globulin fraction). Cataracts.
    • Disseminated granulomatous inflammation in kidneys, heart, eyes, uterus, LN.
    • Only female adult worms suggesting parthenogenic reproduction.
  • Kossiella equi.
    • Coccidian, renal parenchyma.
    • Schizogony (asexual) thought to be in endothelial cells of Bowman’s capsule. Merozoites -> prox convoluted tubules, become second-generation schizonts.
    • Merozoites released into lumen and enter loop of Henle.
      • Develop into microgametocytes (m) and macrogametocytes (f).
      • When pronuclei of micro and macrogametocytes fuse a zygote/sporont develops.
      • Sporozoites develop into sporocysts, released into lumen and pass out in urine.
      • Sporocysts ingested, sporozoites release into GIT, penetrate wall and enter blood to travel to glomeruli.
      • Incidental finding in sections of kidney in Hartmann’s mountain zebra and P horses.
19
Q

List 10 reportable diseases of Equids

A
  • Reportable diseases of specific global concern for equids include:
    • African horse sickness.
    • Western and Venezuelan equine encephalitis viruses.
    • Equine influenza.
    • Equine herpesvirus-1
    • Equine infectious anemia
    • Equine viral arteritis
    • Glanders (Burkholderia mallei)
    • Contagious equine metritis (Taylorella equigenitalis)
    • Equine piroplasmosis
    • Dourine (Trypanosoma equiperdum)
    • Susceptible to Borna virus and vesicular stomatitis virus infections.
20
Q

What are the clinical signs of enterolithiasis in equids?

What type of stones are common?

How is this disease diagnosed?

How is it managed?

A
  • Enterolithiasis.
    • Acute onset of colic. Struvite common. Sand and shavings may cause intestinal impaction, especially in newborns.
    • Dx with radiographs under anesthesia.
    • Rapid surgical intervention often indicated.
    • Reducing dietary alfalfa because of its excessive Mg content may be useful in prevention.
    • Rads for preventive screening.
21
Q

Describe some of the common hoof issues of non-domestic equids.

What species may require more frequent trimming?

How do hoof abscesses typically present? What are some predisposing factors to teh development of hoof abscesses? What are the first signs they are devloping?

A
  • Hoof problems.
    • Routine trimming.
    • Mountain zebras require more freq trims especially if housed on soft or sandy soil.
    • Hoof abscesses should be suspected with severe sudden lameness.
      • Anesthesia, draining abscess is indicated.
      • Predisposing conditions may include excessive feeding of concentrates, enteritis, chronic renal failure, acute intravascular hemolytic anemia.
      • Blood supply to the corium (sensitive laminae of the foot) is interrupted.
        • Union between horny and sensitive laminae breaks down and progresses to separation of the nail at the coronary band.
        • First signs are lameness or discharge at coronary band.
22
Q

What lesions are associated with hypovitaminosis E in equids?

How does this differ from the lesions in other species?

What species appear particularly susceptible?

A
  • Hypovitaminosis E.
    • Degenerative myelopathy in captive Mongolian wild (Przewalski) horses.
      • CS varies from mild ataxia to wide-based gait and stance, uncoordinated movements of hind limbs.
      • Gross and histo lesions in cardiac or skeletal muscle not noted.
      • Most significant lesions are in caudal cervical and cranial thoracic spinal cord.
        • Degeneration, demyelination, astrogliosis ventral and lateral funiculi.
        • Axons in gray matter throughout cord are swollen and degenerate.
        • Plasma alpha-tocopherol < 0.03-0.08 mg/dL (normal > 5, < 3 considered deficient).
      • Due to dietary vitamin E concentrations in feed of affected P horses being low.
23
Q

Describe the following toxicities in equids?

Organophosphate

Red Maple - what lesions are present, what is the toxic principle?

Sycamore seed - what is the toxic principle? what were teh clinical signs and lesions?

A
  • Toxins.
    • Organophosphate toxicity described in Damara zebra after deworming.
    • Red maple (Acer rubrum) – hemolytic anemia in two female Grevy’s zebra with Heinz body formation and leukocytosis.
      • Methemoglobinemia in a female with generalized icterus, hepatic necrosis.
      • Seasonal cases, associated with ingestion of wilted or dried leaves that contain gallic aid.
        • Causes severe oxidative damage to erythrocytes.
    • Sycamore seed (Acer pseudoplanatus) aka sycamore maple.
      • Equine atypical myopathy in a P horse foal.
        • Sudden onset stretching neck and progressive weakness.
        • Chem – markedly increased CK, increased AST, mild increase inorganic P.
        • Neutrophilia, passage of dark brown urine with elevated protein and hemo/myoglobin.
        • Histo – rhabdomyolysis skeletal and cardiac muscle.
        • Organic acid analysis of urine and the plasma acyl carnitine profile consistent with multiple acyl Co-A dehydrogenase deficiency.
          • Inhibition of enzymes by hypoglycin A has been associated with equine atypical myopathy.
          • Fatty acid oxidation in muscle mitochondria is defective and muscle weakness develops.
      • Seeds of the sycamore maple contain hypoglycin A.
24
Q

What is a common congential condition of Plain’s zebras?

What are the clinical signs and lesions of this disease?

A
  • Congenital.
    • Familial degenerative myelopathy.
      • 8/17 Burchell’s zebra foals, progeny of one stallion and two mares.
      • Progressive ataxia between 4-6 mos age, no radiographic or necropsy findings to indicate narrowing of the vertebral canal.
      • Histo – ascending and descending tracts with bilaterally symmetrical demyelination found in spinal cord at lateral and ventral funiculi.
      • Lesions in cervical, thoracic, lumbar, and sacral regions, cranially to medulla oblongata. No lesions in brain.
25
Q

What is a common cause of sudden death in equids?

What other forms of trauma are common in equids?

A
  • Trauma.
    • Fracture of cervical vertebra and femur has occurred during courtships of Somali wild ass.
    • Bite wounds common in equidae.
    • Cervical fractures in captive zebras after collision with enclosure fencing.
      • Often found dead, no history of illness.
26
Q

A recent study evaluated the estrous cycles of the Somali wild ass.

How long is their cycle?

Do they cycle continuously or are they seasonal?

How long is gestation?

Describe the changes in progestagen concentration during pregnancy and prior to parturition.

Describe the changes in estrogen concentration throughout pregnancy.

When do they cycle again after parturition?

A

Kozlowski, C. P., Clawitter, H. L., Thier, T., Fischer, M. T., & Asa, C. S. (2018). Characterization of estrous cycles and pregnancy in Somali wild asses (Equus africanus somaliensis) through fecal hormone analyses. Zoo biology, 37(1), 35-39.

Abstract: Although reproduction in the domestic horse has been well described, less is known about reproduction in wild equids. This study describes endocrine patterns associated with estrous cycles and pregnancy for Somali wild asses (Equus africanus somaliensis), an endangered African equid. Fecal samples were collected three times per week for more than 2 years from five female Somali wild asses at the Saint Louis Zoo; progestagen and estrogen metabolites were quantified using commercially available immunoassays. Progestagen analysis indicated that cycle lengths were 27.2 ± 1.2 days and females cycled throughout the year. Progestagen levels during early pregnancy were low and not sustained above baseline until approximately 40 weeks prior to partition. Concentrations increased markedly around 16 weeks prior to delivery and peaked 2–3 weeks before birth. Fecal estrogen levels also increased significantly starting 40–45 weeks before parturition and reached their maximal value approximately 20 weeks prior to birth. Neither foal heat nor lactational suppression of estrus was observed, and females cycled within 45 days after delivery. These data are the first to describe the reproductive physiology of Somali wild asses. As the species faces increasing threats in the wild, this information may support conservation efforts by assisting with ex situ breeding programs.

  • Other nondomestic equids
    • Wild equid estrus cycles tend to be longer than domestic horses and more like donkeys
    • Gestation longer than domestic horses and donkeys (zebra: 291-406 d, Persian onanger 321-348d) – P horses similar (331-352 d)
      • Somali wild ass was 54-58 weeks (378-406d; mean 395d)
    • Foal heat observed in some nondomestics, lactation ovulation suppression in Persian onangers

Take Home: Progestagen up at 40 weeks prior to parturition, significantly increases at 16 weeks prior, peaks 2-3 weeks prior. Estrogen increases 40-45 weeks prior, peaks 20 weeks prior. No foal heat or lactation suppression of estrus – cycle within 45 days.

27
Q

A recent study compared opioid based protocols in Grevy’s zebra.

How did etorphine compare to thiafentanil (both with an alpha 2) in terms of induction time?

Did the inclusion of ketamine in these protocols affect induction time?

What about the effect of ketamine on recovery time?

A

Stuchin, M., Mama, K. R., Zuba, J. R., Oosterhuis, J. E., Lamberski, N., & Olea-Popelka, F. (2019). A comparison of opioid-based protocols for immobilization of captive grevy’s zebra (equus grevyi). Journal of Zoo and Wildlife Medicine, 50(1), 258-261.

Grevy’s zebra (Equus grevyi) is an endangered species often found in zoological collections. Veterinary care for this species often requires immobilization. This study retrospectively evaluated behavioral and physiological parameters from Grevy’s zebra records after three immobilization protocols: etorphine and alpha-2 agonist (EA2; n = 11); etorphine, alpha-2 agonist, and ketamine (EA2K; n = 16); and thiafentanil, alpha-2 agonist, and ketamine (TA2K; n = 6). Median time to working depth was statistically different (P = 0.03; EA2 = 6.5 min, EA2K = 6.3 min, TA2K = 14.5 min) by the Kruskal–Wallis test. When EA2 + EA2K were combined and compared with TA2K (Wilcoxon rank sum test), median recumbency time (P = 0.02) was also significantly longer (15 min compared with 6 min) for TA2K. There were no significant differences between the groups for physiological parameters or recovery time after reversal. Although all protocols produced anesthesia in Grevy’s zebra, increased time to achieve working depth was observed with the alpha-2 and thiafentanil combinations.

  • Etorphine and alpha2 agents predictable immobilization in this species.
  • This is a retrospective looking at behavioral characteristics and physiological parameters using etorphine and thiafentanil on the basis of immobilization protocols.
  • Treatment groups:
    • Etorphine and alpha 2
    • Etorphine, alpha 2 and ketamine
    • Thiafentanil, alpha 2, ketamine
    • Reversal with naloxone
  • Induction times significantly longer with thiafentanil and alpha 2.
  • Inclusion of ketamine in protocol did not have an overall effect on induction time, physiologic parameters, or the need for supplemental drugs.
    • Recover was longer.
  • Thiafentanil is a viable alternative to etorphine.
28
Q

A recent study evaluated the quality of immobilization and cardiorespiratory effects of an etorphine-medetomidine-azaperone protocol in plains zebra.

What were some of the common complications of this protocol?

How did induction time compare to other protocols?

How were recoveries?

A

Gaudio, E., Hoffman, L. C., Schabort, G. A., Shepstone, C. A., Bauer, G., & De Benedictis, G. M. (2020). Evaluation of the quality of immobilization and cardiorespiratory effects of etorphine-medetomidine-azaperone combination in plains zebras (equus quagga): a pilot study. Journal of Zoo and Wildlife Medicine, 50(4), 988-992.

Abstract: Five free-ranging male (subadults, n = 3; adults, n = 2) plains zebras (Equus quagga) were immobilized using a combination of etorphine (0.017 mg/kg), medetomidine (0.017 mg/kg), and azaperone (0.24 mg/kg) by means of a blank cartridge-fired projector. Time to recumbency was recorded and a descriptive score used to assess the quality of immobilization, manipulation, maintenance, and recovery. Physiological parameters were recorded at 5-min intervals for 20 min. At the end of the procedure, naltrexone (0.23 mg/kg) was administered intramuscularly and time to standing documented. The combination evaluated in this study allowed for successful immobilization and safe recovery of all animals, including during the subsequent 15 days. Despite the good outcome in this pilot study, as a result of the periodic apneic events and hypercapnia documented in the zebras, the authors suggest that physiological parameters be thoroughly monitored when using this protocol. Further studies are needed to improve upon chemical immobilization protocols in free-ranging plains zebras.

  • Observational pilot study: 5 plains zebras were anesthetized in the field in South Africa
  • Age and body weight estimated, darted with etorphine-medetomidine-azaperone
    • Equine weight tape used for more accurate wt estimation once immobilized
  • Anesthetic milestones and physiological parameters recorded throughout procedure
    • etCO2 measured via capnograph attached to intranasal endo-tracheal tube
  • Only etorphine reversed with naltrexone

Results/ discussion

  • A five animals had successful induction and safe recovery
    • No fatalities or renarcotizations noted during the 15 days post-procedure
  • Protocol had shorter time to lateral recumbency then previously assessed protocols (etorphine, ace, hyoscine; etorphine, triflupromazine; etorphine, acepromazine)
    • Rapid induction (4.4+/-2.6min) potentially due to either higher etorphine dosage or medetomidine
  • Bradypenia and self-resolving apnea noted in 3/5 animals; ET CO2 indicative of hypercapnia
    • Remaining vitals otherwise stable throughout procedures
  • All animals stood smoothly on first try, time to recovery (3.8+/-2.3min)
  • Bottom line: the etorphine-medetomidine-azaperone protocol evaluated resulted in successful/ rapid inductions, stable vital parameters, and smooth/ uneventful recoveries
29
Q

A recent study evaluated the cause of fatal intestinal disease in domestic horses.

What were the most common lesions?

What bacteria were the primary causes of these lesions?

Were any age groups more susceptible?

A

Macías-Rioseco, M., Hill, A. E., & Uzal, F. A. (2020). Fatal intestinal inflammatory lesions in equids in California: 710 cases (1990–2013). Journal of the American Veterinary Medical Association, 256(4), 455-462.

Objective: To determine incidences and underlying causes of fatal intestinal inflammatory lesions (FIILs) and demographic characteristics of affected equids necropsied at any of the California Animal Health and Food Safety Laboratory facilities between January 1, 1990, and April 16, 2013.

Animals: 710 equids with FIILs, including colitis, duodenitis, enteritis, enterocolitis, enteropathy, enterotyphlitis, gastritis, gastroenteritis, ileitis, jejunitis, typhlitis, or typhlocolitis, alone or in combination.

Procedures: The medical records were reviewed, and data collected included animal age, sex, geographic origin, necropsy submission date, and breed, purpose, or characteristic of use. Descriptive statistics were compiled and reported as numbers and percentages.

Results: Colitis (323/710 [45.5%]), enteritis (146/710 [20.6%]), and typhlocolitis (138/710 [19.4%]) were the most common FIILs, and the underlying cause of most FIILs was categorized as either undetermined (465/710 [65.5%]) or bacterial (167/710 [23.5%]). The most common bacteria responsible for FIILs were Clostridium spp and Salmonella spp.

Conclusions and Clinical Relevance: Results indicated that the underlying cause for most FIILs could not be identified; however, when it was identified, it was most commonly bacterial and typically Clostridium spp or Salmonella spp, which could be useful information for practitioners when evaluating and managing horses and other equids with intestinal distress. In addition, results underscored the need for improved diagnostic procedures and strategies to determine underlying causes of FIILs in equids. Knowledge of the most common FIILs and their underlying causes may help in diagnosing and mitigating intestinal disease in equids.

  • Key Points:
    • Previous studies showed Salmonella spp and Clostridium difficile are the most important infectious causes of inflammation in the alimentary tract of equids.
      • Mainly characterized clinically by diarrhea or colic and pathologically by enteritis, typhlitis, or colitis.
    • Other infectious agents: Rhodococcus equi, Clostridium perfringens, rotaviris, coronavirus, and parasites (Strongylus). Toxicoses (oleandrin or drugs i.e. NSAIDs).
    • Colitis (45%), enteritis (21%), and typhlocolitis (20%) were the three most common primarily FIILs.
    • Least common – enterotyphlitis and gastroenteritis.
    • Neonatal animals had enteritis more commonly than other FIILs, other ge groups colitis was more common.
    • Clostridium more commonly isolated from animals with colitis or enteritis.
      • C. difficile > C. perfringens > C. sordelii > C. piliforme > C. tetani, other
    • Salmonella isolated more frequently from animals with typhlocolitis.
      • S. enterica subtypes Typhimurium, Newport, Saint Paul, Krefeld, Arizonae, Enteritidis, Anatum.
  • Takeaways: Colitis > enteritis > typhlocolitis were most common primary FIILs. Majority undetermined etiology followed by bacterial – Clostridium (colitis, enteritis) and Salmonella (typhlocolitis) most common isolates.
30
Q

A recent study described pituitary pars intermedia dysfunction in nondomestic equids.

How common is PPID in domestic horses?

What are the typical clincial signs?

How is it diagnosed?

How were these animals treated?

What findings were seen on necropsy of these animals?

A

Shotton, J. C., Justice, W. S., Salguero, F. J., Stevens, A., & Bacci, B. (2018). PITUITARY PARS INTERMEDIA DYSFUNCTION (EQUINE CUSHING’S DISEASE) IN NONDOMESTIC EQUIDS AT MARWELL WILDLIFE: A CASE SERIES. ONE CHAPMAN’S ZEBRA (EQUUS QUAGGA CHAPMANI) AND FIVE PRZEWALSKI’s HORSES (EQUUS FERUS PRZEWALSKII). Journal of Zoo and Wildlife Medicine, 49(2), 404-411.

Abstract: Pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease, is widely reported in middle-aged to older domestic equids but to date reported in only one nondomestic equid, the onager (Equus hemionus onager). This case series reports clinical, hematological, and pathological findings consistent with PPID in two further equid species: one Chapman’s zebra (Equus quagga chapmani) and five Przewalski’s horses (Equus ferus przewalskii). The case series reports basal adrenocorticotropic hormone (ACTH) testing as a method to diagnose and monitor PPID in zoological equids and the use of pergolide mesylate to reduce basal ACTH concentration and reduce clinical signs associated with PPID. Gross and histopathological examinations of the pituitary gland in four of these cases revealed either pars intermedia adenomas or adenomatous hyperplasia, similar to pathological findings in domestic equids affected by PPID. These findings suggest that clinicians working with nondomestic equids should be aware of this condition and consider screening for it routinely, particularly given that improvements in management and veterinary care for exotic animals are resulting in a more aged captive population. Early diagnosis and treatment of PPID may prevent the development of painful clinical sequelae and therefore improve the welfare of zoo equids.

  • PPID affects up to 30% of older horses
  • Clinical signs include hypertrichosis, laminitis, polyuria, polydipsia, muscle wasting
  • Diagnosed with high adrenocorticotropic hormone (ACTH) – normal range < 29 pg/mL
    • Other testing options – thyrotropin stimulating hormone or dexamethasone stimulation tests
  • Anesthetized with 2.5 mg/kg ketamine + medetomidine 0.1 mg/kg OR 0.05-0.1 mg/kg detomidine + 0.03-0.06 butorphanol
  • Treated with pergolide 1 mg daily (3 mcg/kg PO q24h)
  • Other clinicopathologic findings – elevated GGT

Take Home: PPID may be playing a role in older non-domestic equids and testing should be done for any showing signs

References:

  • Schott H, Andrews F, Durham A, Frank N, Hart K, Kritchevsky J, McFarlane D, Tadros L. Recommendations for the diagnosis and treatment of pituitary pars intermedia dysfunction (PPID) [Internet]. c2017 [cited 5 December 2017]. Available from https://sites. tufts.edu/equineendogroup/files/2017/11/2017-EEG- Recommendations-PPID.pdf
31
Q

A recent study described gastric ulcers and associated risk factors in wild equids.

What species show a higher disposition for gastric ulceration?

How did age affect the prevalence adn severity of gastric ulcers?

Where were the ulcers located?

What are some risk factors for ulcer development in domestic horses?

What risk factor was found for these wild equids?

A

Lamglait, B., Vandenbunder-Beltrame, M., Trunet, E., & Lemberger, K. (2017). Description of gastric ulcers and of their suspected, associated risk factors in deceased wild equids at the réserve africaine de sigean, france (2010–2016). Journal of Zoo and Wildlife Medicine, 48(3), 668-674.

Abstract: Gastric ulcers are common in domestic horses and foals, affecting at least 90% of unmedicated racehorses in active training. Despite these high prevalences in domestic horses, literature about this condition in wild equids is almost nonexistent. The presence of gastric ulcers was evaluated at necropsy in six species of wild equids that died at the Re´serve Africane de Sigean, a safari park in the south of France from 2010 to 2016. Among the 55 individuals that died during that period, a description of the gastric mucosa was available in 82% (45/55) of cases. Considering the cases for which a description of the gastric mucosa was available, the prevalence of gastric ulcers was 64% (29/45). The highest prevalences were noted in Grant’s zebra (Equus quagga boehmi) and Hartmann’s mountain zebra (Equus zebra hartmannae) at 83% and 100%, respectively. In contrast to what is reported in domestic foals, gastric ulcerations were only diagnosed in one foal (out of 11 foals necropsied). The higher prevalence was noted in young individuals (3–36 mo old) at 93% (14/15); the lesions observed consisted mainly of single to multiple, superficial lesions, of which, only the mucosa was missing; these superficial lesions are often considered not clinically significant. The prevalence was lower for adults (74%; 14/19), but lesions were deeper or with a hyperemic or inflammatory appearance. All the lesions observed were located in the gastric, nonglandular, stratified squamous mucosa, along the margo plicatus. No statistical correlation could be found between the development of gastric ulcers and an ongoing, chronic pathologic process or a digestive tract pathology. The detection of gastric ulcers was, therefore, significantly greater in wild equids isolated in smaller enclosures. Nevertheless, additional larger-scale research is needed to point out predisposing factors in equids under human care.

  • Gastric ulcers common in domestic horses and foals, especially in performance disciplines, recent changes in housing or social interactions, and illness.
  • Grant’s and Hartmann’s zebras demonstrated significantly greater proportions of gastric ulcers compared to overall population.
  • Low in foals, differs from domestic horses.
  • 3-36 mos old significantly more affected. Adults had more severe lesions. Not correlated with severity of CS in this study. Also no correlation between ulcers and other chronic GI conditions.
  • All gastric ulcers along the margo plicatus, particularly in the saccus caecus and squamous mucosa (non-glandular) along the lesser and greater curvatures.
  • Factors implicated in causing ulcers in horses – fasting, gastric acid clearance (motility and emptying), aggressiveness of gastric acid, pepsin, and volatile fatty acids produced from fermentation of soluble carbohydrates. Anything modifying one or more of those components can lead to EGUS.
    • Intermittent feeding with high-grain diets, physical and environmental stress i.e. transport stress and stall conferment, lack of exposure to other conspecifics, chronic administration of NSAIDs. Neonatal domestic foals significant risk for perforating peptic ulcers, gastric mucosa is not full thickness at birth.
  • Detection of ulcers significantly greater in wild equids isolated in enclosures < 75 m^2.

Takeaways: Low prevalence in foals, higher in 3-36mos old, more severe in adults, along the margo plicatus in all cases. Associated with individuals isolated in small enclosures.

32
Q

A recent study evaluated potential predictor variable for PCR diagnosis of Anaplasma phagocytophilum in equids.

What are the common clinical signs of this disease?

What are teh common clinicopathologic changes, in addition to clinical signs, that should suggest that you test?

Why do PCR and not just a blood smear?

A

Fielding, C. L., Rhodes, D. M., Howard, E. J., & Mayer, J. R. (2018). Evaluation of potential predictor variables for PCR assay diagnosis of Anaplasma phagocytophilum infection in equids in Northern California. American journal of veterinary research, 79(6), 637-642.

Abstract:

OBJECTIVE: To identify clinical or clinicopathologic variables that can be used to predict a positive PCR assay result for Anaplasma phagocytophilum infection in equids.

ANIMALS: 162 equids.

PROCEDURES: Medical records were reviewed to identify equids that underwent testing for evidence of A phagocytophilum infection by PCR assay between June 1, 2007, and December 31, 2015. For each equid that tested positive (case equid), 2 time-matched equids that tested negative for the organism (control equids) were identified. Data collected included age, sex, breed, geographic location (residence at the time of testing), physical examination findings, and CBC and plasma biochemical analysis results. Potential predictor variables were analyzed by stepwise logistic regression followed by classification and regression tree analysis. Generalized additive models were used to evaluate identified predictors of a positive test result for A phagocytophilum.

RESULTS: Total lymphocyte count, plasma total bilirubin concentration, plasma sodium concentration, and geographic latitude were linear predictors of a positive PCR assay result for A phagocytophilum. Plasma creatine kinase activity was a nonlinear predictor of a positive result.

CONCLUSIONS AND CLINICAL RELEVANCE: Assessment of predictors identified in this study may help veterinarians identify equids that could benefit from early treatment for anaplasmosis while definitive test results are pending. This information may also help to prevent unnecessary administration of oxytetracycline to equids that are unlikely to test positive for the disease.

  • Clinical signs – febrile, ataxia, edema, petechial hemorrhage
  • Common lab changes – leukopenia, anemia, thrombocytopenia
  • PCR can detect disease before blood smear

Take Home: Low lymphocytes, high bilirubin, high sodium, lower latitudes more likely to be positive

33
Q

A recent study evaluated the causes of death in feral horses in Japan.

What type of virus is Japanese encephalitis virus? What are its natural viremic amplifiers?

How commonly were these horses seropositive?

What was the most common pathologic finding in these horses?

A

Niazmand, M. H., Hirai, T., Ito, S., Habibi, W. A., Noori, J., Hasheme, R., & Yamaguchi, R. (2019). Causes of death and detection of antibodies against japanese encephalitis virus in misaki feral horses (equus caballus) in southern japan, 2015–17. Journal of wildlife diseases, 55(4), 804-811.

ABSTRACT: We performed postmortem examinations on seven Misaki feral horses (Equus caballus) and evaluated Misaki feral horses, Japanese wild boars (Sus scrofa leucomystax), domestic pigs (Sus scrofa), and wild Japanese macaques (Macaca fuscata fuscata) from 2015 to 2017 in Cape Toi, Kushima, Miyazaki Prefecture, southern Japan, for antibodies against Japanese encephalitis virus (JEV). Strongylus vulgaris infection with severe arterial lesions and hemomelasma ilei was present in all necropsied horses. We frequently found intestinal ulcers, perihepatitis filamentosa, and poor body condition. We recorded degenerative arthropathy in metacarpophalangeal joints in two cases and a fracture of the rib with diaphragmatic rupture in one case. A total of 73% (177/242) of horses were seropositive for JEV as tested by hemagglutination inhibition(HI). The HI data also revealed that 74% (59/80) of the wild boars, 67% (60/90) of the pigs, and 29% (22/75) of the wild monkeys were seropositive for JEV. Our findings showed that Strongylus spp. are still a risk to horses in this region, and that environmental factors such as topographic location of the pasture and steep slope may have caused of degenerative arthropathy and bone fracture. Our results showed that JEV is endemic in Japan. The wild boars and pigs were presumed to act as strong amplifiers and sources of infection, with subsequent risk to humans.

  • Japanese encephalitis virus (JEV) is transmitted by mosquitoes and severe zoonotic disease with neurologic symptoms - Family Flaviviridae, Genus Flavivirus
    • Swine (Sus scrofa) and birds of the family Ardeidae are viremic amplifiers
  • N = 7 pathologic findings and N = 242 samples
  • Cranial mesenteric arteritis and hemomelasma ilei caused by S. vulgaris larvae infection found in all horses
    • Perihepatitis in most horses likely from migration of S. edentates
    • Many were emaciated
  • Degenerative arthropathy and lameness in 2 horses 🡪 topographic conditions in pastures are predisposing factor
  • More common in older horses (>10yr)
  • Strongylosis infection rate decreasing due to anthelmintic drugs, but NOT sufficient to break life cycle
  • JEV is endemic in Misaki feral horses, wild boars, and domestic pigs 🡪 potential strong amplifiers of JEV
  • JEV is endemic in macaques
34
Q

A recent study described clinical disease caused by Anaplasma phagocytophilum in Przewalski’s horses.

Were do the morulae form in this disease?

What are the typical clinical signs? Is severity affected by age?

What diagnostics can be done to confirm infection? What was a unique clinicopathologic finding in these cases?

How were these animals treated?

A

Sim, R. R., Joyner, P. H., Padilla, L. R., Anikis, P., & Aitken-Palmer, C. (2017). Clinical disease associated with Anaplasma phagocytophilum infection in captive Przewalski’s horses (Equus ferus przewalskii). Journal of Zoo and Wildlife Medicine, 48(2), 497-505.

Abstract: Anaplasma phagocytophilum is a tick-borne pathogen of domestic horses and the causative agent of equine granulocytic anaplasmosis. This case series describes three confirmed cases of clinical anaplasmosis, and a fourth case of presumptive anaplasmosis in Przewalski’s horses (Equus ferus przewalskii) housed at the Smithsonian Conservation Biology Institute from 2008 to 2014. Clinical signs varied among individuals with affected horses exhibiting lethargy, weakness, pyrexia, hypophagia, reluctance to move, or ataxia. Anaplasmosis cases were confirmed with a combination of identification of neutrophilic inclusions (morulae) on peripheral blood smear, positive polymerase chain reaction (PCR) testing of whole blood, or convalescent titers. All animals recovered after antimicrobial therapy with oxytetracycline. Diagnosis should be made by a combination of clinical signs plus identification of morulae or positive A. phagocytophilum PCR. Treatment is curative using oxytetracyline intramuscularly or intravenously followed by daily therapy with oxytetracyline or minocycline for 14–30 days. The authors recommend that A. phagocytophilum infection be included on any differential list for Przewalski’s horses presenting with fever or ataxia within or near an enzootic area.

  • Equine granulocytic anaplasmosis – Anaplasma phagocytophilum
    • Formation of morulae – granular aggregates within the cytoplasm of neutrophils
  • Clinical signs
    • Recumbency, lethargy, ataxia, ptosis, pyrexia, prolonged CRT, leukopenia, thrombocytopenia, morulae in neutrophils
    • Vasculitis associated cerebral edema leads to the ataxia
    • More mild signs in younger animals (also reported in domestic horses)
  • Diagnostics
    • Morulae in neutrophils, PcR testing, serology (four-fold increase in titers)
    • Hypophosphatemia was seen in these cases, but this isn’t typical in domestic horses
  • Treatment
    • 5% dextrose IV, ceftiofur IV, flunixin IV, vitamin E IM
    • Oxytetracycline 10 mg/kg IM q12h x 10 d
    • Minocycline PO – penetrates CNS better than doxycycline

Take Home: Anaplasmosis can cause clinical EGA as in domestic horses, diagnose with morulae on smears (PCR or increased titers in serology), treat with doxycyclines

35
Q

A recent study investigated the prevalence of antibodies against Anaplasma phagocytophilum in managed Przewalksi’s horses.

What taxa are affected by A. phagocytophilum?

How is it transmitted?

How prevalent were the antibodies in these horses in this study?

Did all these animals have clinical disease?

A

Sim, R. R., Padilla, L. R., Joyner, P. H., Anikis, P., & Aitken-Palmer, C. (2017). Survey of anaplasma phagocytophilum antibodies in captive przewalski’s horses (equus ferus przewalskii). Journal of Zoo and Wildlife Medicine, 48(2), 506-509.

Abstract: Anaplasma phagocytophilum (formerly Ehrlichia equi) is a tickborne pathogen of domestic horses and the causative agent of equine granulocytic anaplasmosis. After the occurrence of clinical anaplasmosis in a Przewalski’s horse (Equus ferus przewalskii) housed at the Smithsonian Conservation Biology Institute in 2008, opportunistic serosurveillance of the herd was initiated. From 2008 to 2014, 57 serum samples were collected from 27 individuals (10 males; 17 females). Using indirect immunofluorescent antibody assays for anti–Anaplasma phagocytophilumantibodies, it was determined that prevalence was 53%. No significant sex differences were identified. A statistical association between increasing age and seropositive status suggests cumulative risk of exposure to Anaplasma phagocytophilum. After exclusion of four clinical cases of anaplasmosis, it was found that 22–57% of those sampled each year were seropositive and clinically normal, suggesting that the majority of Przewalski’s horses develop subclinical or self-limiting anaplasmosis after exposure to A. phagocytophilum.

  • Anaplasma phagocytophilum – tickborne pathogen of carvnivores, rujminants, humans, domestic horses
    • Cause of equine granulotic anaplasmosis (EGA)
    • Transmitted by Ixodes spp ticks
    • Genetic variation influences morbidity

Take Home: Anaplasmosis appears to be self-limiting in many Przewalski’s horses but could be a threat to wild populations

36
Q

A recent study described a hydatid cyst in the liver of a managed Przewalski’s horse.

What cestode species caused this?

What is the typical sylvatic cycle of this parasite?

A

Milnes, E., Delnatte, P., Dutton, C. J., Brouwer, E., Cai, H. Y., Smith, D. A., & Peregrine, A. S. (2018). Echinococcus equinus hydatid cyst in the liver of a przewalski’s horse (equus przewalskii) in a canadian zoo. Journal of Zoo and Wildlife Medicine, 49(4), 1047-1050.

Abstract: A 23-yr-old captive-born Przewalski’s horse mare (Equus przewalskii) was euthanized at a Canadian zoo because of severe colic resulting from rupture of a jejunal pseudodiverticulum. An incidental finding of an encysted larval cestode within a hepatic granuloma was diagnosed on histopathology. Gel-based polymerase chain reaction (PCR) on liver tissue was positive for Echinococcus granulosus sensu lato, and deoxyribonucleic acid sequencing of the PCR product was 100% homologous with Echinococcus equinus. This appears to be the first molecular confirmation of E. equinus in North America, and the first report of cystic echinococcosis in a Przewalski’s horse.

  • Echinococcus species are obligate two host parasites of mammals
  • E. equinus – intermediate hosts are equids, lemurs also reported
    • Sylvatic cycle – lions, black-backed jackals & zebras in Africa
  • This P horse acquired the infection locally as it was captive born

Take Home: Echinococcus can be acquired locally in North America and non-domestic species are affected as well

37
Q

A recent study described the pharmacokinetics of firocoxib in horses.

Describe the pharmacophysiology of COX-1 and COX-2 receptors.

What are the COX1 : COX2 selectivity ratios of flunixin, phenylbutazone, meloxicam, and firocoxib? (Higher ratios mean more COX-2 activity)

Are any side effects seen with firocoxbi?

Which drugs (COX-1 or COX-2) are better for colic?

A

Ziegler, A., Fogle, C., & Blikslager, A. (2017). Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses. Journal of the American Veterinary Medical Association, 250(11), 1271-1274.

Abstract: Nonsteroidal anti-inflammatory drugs work through inhibition of cyclo- oxygenase (COX) and are highly effective for the treatment of pain and inflammation in horses. There are 2 clinically relevant isoforms of COX. Cyclooxygenase-1 is constitutively expressed and is considered important for a variety of physiologic functions, including gastrointestinal homeostasis. Thus, NSAIDs that selectively inhibit COX-2 while sparing COX-1 may be associated with a lower incidence of adverse gastrointestinal effects. Various formulations of firocoxib, a COX-2–selective NSAID, labeled for use in horses are available in the United States. Equine practitioners should know that the FDA limits the use of firocoxib to formulations labeled for horses, regardless of price concerns. In addition, practitioners will benefit from understanding the nuances of firocoxib administration, including the importance of correct dosing and the contraindications of combining NSAIDs. Together with knowledge of the potential advantages of COX-2 selectivity, these considerations will help veterinarians select and treat patients that could benefit from this new class of NSAID. (J Am Vet Med Assoc 2017;250 :1271–1274)

  • Pharmacophysiology
    • Cox-1 is a beneficial isoform, Cox-2 is associated with inflammation and pain
    • Cox-2 still has functions in the kidney so renal effects are a possibility
  • Flunixin & phenylbutazone have near 1 Cox-1:Cox-2 Ratios
  • Meloxicam 3-4, Firocoxib 200
  • Firocoxib
    • Renal issues still possible
    • 0.1 mg/kg PO q24h – 80% of horses with arthritis had improvement
  • Cox-2 drugs are better for colic (intestinal barrier recovery)

Take Home: You can use firocoxib in horses.

References:

  • Tomlinson JE, Wilder BO, Young KM, et al. Effects of flunixin meglumine or etodolac treatment on mucosal recovery of equine jejunum after ischemia. Am J Vet Res 2004;65:761–769
  • Cook VL, Meyer CT, Campbell NB, et al. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum. Am J Vet Res 2009;70:992–1000.
  • Naylor RJ, Taylor AH, Knowles E, et al. Comparison of flunix- in meglumine and meloxicam for postoperative management of horses with strangulating small intestinal lesions. Equine Vet J 2014;46:427–434.
38
Q

A recent study evaluated the use of valacyclovir to treat equine herpes 1 in horses.

What are the common clinical signs of EHV1?

What is valacyclovir? Is it well absorbed early?

How did treatment compare between those started before viral challenge or those when fever was detected?

How effective was treatment?

A

Maxwell, L. K., Bentz, B. G., Gilliam, L. L., Ritchey, J. W., Pusterla, N., Eberle, R., … & Whitfield, C. (2017). Efficacy of the early administration of valacyclovir hydrochloride for the treatment of neuropathogenic equine herpesvirus type-1 infection in horses. American journal of veterinary research, 78(10), 1126-1139.

OBJECTIVE To determine whether prophylactic administration of valacyclovir hydrochloride versus initiation of treatment at the onset of fever would differentially protect horses from viral replication and clinical disease attributable to equine herpesvirus type-1 (EHV-1) infection.

ANIMALS: 18 aged mares.

PROCEDURES: Horses were randomly assigned to receive an oral placebo (control), treatment at detection of fever, or prophylactic treatment (initiated 1 day prior to viral challenge) and then inoculated intranasally with a neuropathogenic strain of EHV-1. Placebo or valacyclovir was administered orally for 7 or 14 days after EHV-1 inoculation or detection of fever (3 horses/group). Effects of treatment on viral replication and clinical disease were evaluated. Plasma acyclovir concentrations and viremia were assessed to determine inhibitory concentrations of valacyclovir.

RESULTS: Valacyclovir administration decreased shedding of virus and viremia, compared with findings for control horses. Rectal temperatures and clinical disease scores in horses that received valacyclovir prophylactically for 2 weeks were lower than those in control horses. The severity of but not the risk for ataxia was decreased by valacyclovir administration. Viremia was decreased when steady-state trough plasma acyclovir concentrations were > 0.8 μg/ mL, supporting the time-dependent activity of acyclovir.

CONCLUSIONS AND CLINICAL RELEVANCE: Valacyclovir treatment significantly decreased viral replication and signs of disease in EHV-1–infected horses; effects were greatest when treatment was initiated before viral inoculation, but treatment was also effective when initiated as late as 2 days after inoculation. During an outbreak of equine herpesvirus myeloencephalopathy, antiviral treatment may be initiated in horses at various stages of infection, including horses that have not yet developed signs of viral disease

  • EHV-1 – classically upper respiratory & abortive disease; neurologic signs in older horses
  • Valacyclovir is well absorbed orally – prodrug for acyclovir
  • Three groups – start v prior to challenge, start v when fever is detected – 27 mg/kg PO loading q8h x 2d, maintenance 18 mg/kg PO q12h
  • Viral detected days 5-9 following inoculation
  • Treatment reduced nasal shedding, viremia, & clinical signs

Take Home: Give valacyclovir prophylactically in horse exposed in an outbreak to reduce signs and the severity of the outbreak

39
Q

A recent study evaluated the management of equine sarcoids in wild equids.

What species appear particularly susceptible to sarcoids? Why is this theorized?

What are sarcoids? What are the various forms?

What is the etiologic agent that causes sarcoids? Is infection alone sufficient to produce the tumor?

What was the most successful treatment in these cases?

Was there a location predilection?

A

Journal of Zoo and Wildlife Medicine 52(1): 28–37, 2021

EQUINE SARCOIDS IN CAPTIVE WILD EQUIDS: DIAGNOSTIC AND CLINICAL MANAGEMENT OF 16 CASES—A POSSIBLE PREDISPOSITION OF THE EUROPEAN COHORT OF SOMALI WILD ASS (EQUUS AFRICANUS SOMALIENSIS)?

Christian Wenker, Dr med vet, Dipl ECZM (ZHM), Stefan Hoby, Dr med vet, Dipl ECZM (ZHM), Beatrice L. Steck, Anna Sophie Ramsauer, Dr med vet, PhD, Sohvi Blatter, DVM, PhD, Dipl ECVP, and Kurt Tobler, PhD – Reviewed by MSM

Abstract: Equine sarcoids (ES) were diagnosed in 12 Somali wild asses (SWA) (Equus africanus somaliensis) from 10 different institutions of the SWA European Endangered Species Programme from 1976 to 2019. Samples of surgically excised masses, biopsies, or necropsy samples were submitted for histologic and virologic analysis. In addition, tissue samples from one onager (Equus hemionus onager), one kulan (Equus hemionus kulan), and two Hartmann’s mountain zebras (HMZ) (Equus zebra hartmannae) were examined. Histology confirmed the diagnosis of ES exhibiting the typical microscopic features. Polymerase chain reaction detected bovine papillomavirus type 1 (BPV1) DNA in eight SWA samples and bovine papillomavirus type 2 (BPV2) DNA in one SWA sample. The onager, kulan, and one HMZ sample tested positive for BPV1. The other HMZ tested positive for BPV1 and BPV2. This is the first report of ES in an onager. Surgical excision was the treatment elected by most veterinarians. A follow-up survey of the cases over several years after clinical diagnosis and therapy revealed variable individual outcome with ES recurrence in four cases. Three SWA and the kulan were euthanized due to the severity of the lesions. Nine affected SWA were males with seven having a sarcoid located at the prepuce. Because a genetic disposition is a risk factor for the development of ES in horses, this may also be true for endangered wild equids with few founder animals in their studbook history. Innovative approaches regarding therapy and prevention of ES in wild equids are therefore highly encouraged.

Key Points:

  • Somali wild ass – critically endangered – 600 individuals in fragmented habitat
    • All animals in managed care descended from 17 wild-caught individuals
  • Equine Sarcoids
    • Fibroblastic skin tumor with an epidermal component – most common skin neoplasm in equids
    • Various forms – occult, verrucous, nodular, fibroblastic, mixed, malevolent
    • Surgical excision, cryotherapy, hyperthermia, radiotherapy, immunotherapy all used with varying degrees of success
    • Bovine papillomavirus type 1,2,3 detected – shared between both bovids and equids
      • BPV infection alone is not sufficient to produce disease – different leukocyte antigen haplotypes and skin wounds appear to play a role in developing disease
  • These cases
    • 2 ES on their head, others on thorax, abdomen, teats, and prepuce
    • Most ES were nodular and fibroblastic with different degrees of ulceration causing substantial irritation and pain
    • Radical excision was the most common treatment – 5/9 had complete resolution, 2/9 had repeated surgery
    • All SWA tissue samples tested positive for BPV on PCR
    • Two Hartman mountain zebras and one onanger cases were also included which also showed BPV positive tissue – soft tissue sarcomas were a rele-out in some of these due to different histology
  • SWA & HMZ both have high incidences – both also have founder effected
  • NA SWA are less commonly affected
  • Prevention – insect repellent, immunotherapeutics being developed in horses, a vaccine could provide some protection similar to human papillomaviruses but is not yet available
  • Radical excision had the most successful outcome

Take-Home: Equine sarcoids is common in SWA & HPZ and should be treated with excision

References:

· Epperson ED, Castleman WL. Bovine papillomavirus DNA and S100 profiles in sarcoids and other cutaneous spindle cell tumors in horses. Vet Pathol. 2017;54(1):44–52

40
Q

A recent study evaluated dust-bathing behaviors of African herbivores (zebra, wildebeest, elephant).

What was the etiologic agent they were concerned about?

What are the various disease forms?

How is it typically transmitted in herbivores?

What did they find about the relationship of dust-bathing sites and this pathogen?

A

DUST-BATHING BEHAVIORS OF AFRICAN HERBIVORES AND THE POTENTIAL RISK OF INHALATIONAL ANTHRAX

JWD 2018 54(1) 34-44

Abstract: Anthrax in herbivorous wildlife and livestock is generally assumed to be transmitted via ingestion or inhalation of Bacillus anthracis spores. Although recent studies have highlighted the importance of the ingestion route for anthrax transmission, little is known about the inhalational route in natural systems. Dust bathing could aerosolize soilborne pathogens such as B. anthracis, exposing dust-bathing individuals to inhalational infections. We investigated the potential role of dust bathing in the transmission of inhalational anthrax to herbivorous wildlife in Etosha National Park, Namibia, an area with endemic seasonal anthrax outbreaks. We 1) cultured soils from dust-bathing sites for the presence and concentration of B. anthracis spores, 2) monitored anthrax carcass sites, the locations with the highest B. anthracis concentrations, for evidence of dust bathing, including a site where a zebra died of anthrax on a large dust bath, and 3) characterized the ecology and seasonality of dust bathing in plains zebra (Equus quagga), blue wildebeest (Connochaetes taurinus), and African savanna elephant (Loxodonta africana) using a combination of motion-sensing camera traps and direct observations. Only two out of 83 dust-bath soils were positive for B. anthracis, both with low spore concentrations (20 colony-forming units per gram). We also detected no evidence of dust baths occurring at anthrax carcass sites, perhaps due to carcass-induced changes in soil composition that may deter dust bathing. Finally, despite observing some seasonal variation in dust bathing, preliminary evidence suggests that the seasonality of dust bathing and anthrax mortalities are not correlated. Thus, although dust bathing creates a dramatic cloud of aerosolized soil around an individual, our microbiologic, ecologic, and behavioral results in concert demonstrate that dust bathing is highly unlikely to transmit inhalational anthrax infections.

· Bacillus anthracis - causative agent of anthrax

o forms spores capable of surviving in environment for decades

· 3 forms based on the route of infection: gastrointestinal, pulmonary, or cutaneous

o lethal doses for pulmonary anthrax lower than for gastrointestinal anthrax

· In herbivores, anthrax is primarily transmitted through ingestion of vegetation or soil contaminated with B. anthracis spores

· Inhalation possible - dust bathing postulated as a behavior facilitating pathogen exposure

· An unmanaged wildlife anthrax system in Etosha National Park, Namibia was studied

o Documented ecology and seasonality of dust bathing in plains zebra, blue wildebeest, and African savanna elephant

o Tested soils from dust-bath sites for B. anthracis and monitored anthrax carcass sites for evidence of dust bathing

o 2% of dust bathing sites were positive for B. anthracis spores

o dust bathing was not detected for any species at the 13 camera-monitored anthrax carcass sites

· B. anthracis occurs in low concentrations in dust bathing site soils, making inhalational anthrax transmission as result of dust bathing highly unlikely

o no evidence to support association between seasonal timing of dust bathing and anthrax cases in any of study species

§ no relationship between elephant dust-bathing behaviors and temperature in the dry seasons

§ seasonality of anthrax in zebra and wildebeest attributed to grazing at carcass sites exposing individuals to gastrointestinal anthrax primarily during wet seasons

41
Q

A recent paper evaluated an outbreak of Equine Herpes 9 in a mixed species exhibit.

What were the clinical signs seen in the affected zebra?

What are the clinical signs seen with EHV4? What about EHV1? And EHV9?

What lesions were seen on the animals that died?

How were the others treated?

What other species were housed in the exhibit? Were any other affected?

A

Journal of Zoo and Wildlife Medicine, 52(2) : 774-778

EQUID ALPHAHERPESVIRUS 9 OUTBREAK ASSOCIATED WITH MORTALITY IN A GROUP OF GREVY’S ZEBRA (EQUUS GREVYI) HOUSED IN A MIXED-SPECIES EXHIBIT

Antoine Leclerc, DVM, Dipl ECZM (ZHM), Baptiste Mulot, DVM, Nicolas Goddard, DVM, Amelie Nicolau, DVM, Gabrielle Sutton, MSc, Romain Paillot, PhD, HDR, Karin Lemberger, DVM, Dipl ACVP, Stephane Pronost, MSc, PhD, HDR, and Loıc Legrand, MSc, PhD

Abstract: A herd of seven captive-born Grevy’s zebras (Equus grevyi) experienced an outbreak of nasal discharge and sneezing. Clinical signs, including lethargy and anorexia, were severe and acute in three animals, including a 16-mo-old male that died within 48 h. Treatment of two severely affected zebras included valacyclovir (40 mg/kg PO), meloxicam (0.6 mg/kg IM/PO), and cefquinome (2.5 mg/kg IMq48h). An adult female improved rapidly, and clinical signs resolved within 48 h of treatment. Administration of valacyclovir pellets was very complicated in a 2-mo-old female, and death occurred within 48 h. Histologic examination of the two individuals that died revealed severe fibrinonecrotic interstitial pneumonia with prominent hyaline membranes and type II pneumocyte hyperplasia. Additionally, the 16-mo-old male presented systemic endothelial activation with vascular thrombosis and necrosis and mild nonsuppurative meningoencephalitis. Herpesviral DNA was detected in the lungs of both individuals by nested polymerase chain reaction. The nucleic acid sequence of the amplicons showed 100% similarity with previously published equid alphaherpesvirus 9 sequences. Three additional animals developed mild nasal discharge only and recovered spontaneously. The zebras shared housing facilities with other species, including white rhinoceros (Ceratotherium simum), reticulated giraffe (Giraffa camelopardalis reticulata), and several antelope species. None of these animals showed clinical signs. Additionally, nasal swabs and whole blood samples were collected from cohoused white rhinoceroses (n=3) and springboks (Antidorcas marsupialis, n=3) as well as nasal swabs from cohoused reticulated giraffes (n = 4). Nucleic acid sequence from equid herpesviruses was not detected in any of these samples. The source of the infection in the zebras remains unclear.

· Equine herpesvirus 4 (EHV-4) associated with respiratory infection

· Equine herpesvirus 1 (EHV-1) associated with respiratory infection, neurological disease and abortion.

· EHV-9, is closely related to EHV-1 and has been shown to exhibit similar pathogenicity

o EHV 1+9 seropositivity reported in zebras often with little or no signs of disease (greater seropositivity in free-ranging zebras). One report of EHV9 encephalitis in a Grevy’s zebra.

o Grevy’s zebras are considered an EHV9 reservoir

· Aim: Describe a case series of EHV9 infection and mortality in Grevy’s zebra

· Seven Grevy’s zebra in mixed species habitat

o 3/7 presented acutely with lethargy, decreased appetite, nasal discharge and sneezing

§ One animal became laterally recumbent and died 2 days later

§ Other 2 cases were milder but progressed to increased nasal discharge and thick exudate

· Treated with valacyclovir, cefquinome and meloxicam in the two remaining animals

· One animal recovered within 48 hours. Other animal (2 mo) had difficulty accepting the valacyclovir pellets and died within 4 days of the onset of clinical signs

· Three other zebras in herd developed nasal discharge

· Necropsy: pulmonary edema and congestion, fibrinonecrotic pneumonia, fibrinonecrotic rhinitis, epicardial hemorrhage and musculoskeletal necrosis. Case 1 also had vascular thrombosis and meningoencephalitis

· EHV9 isolated from lung tissue

· Nasal swabs from cohoused rhinos, springbok, giraffe were all negative. Remaining four zebras negative on nasal swabs 6 months after outbreak.

Take home:Two cases of fatal EHV9 infection in Grevy’s zebras from a mixed species habitat. Both respiratory and neurologic lesions were noted following EHV9 infection. The source of the outbreak was undetermined.

42
Q

A recent study compared one versus two dart protocols in Przewalski’s horses.

What were the two different protocols?

How did induction differ?

Did animals need supplementation for intubation?

Compare the three ultrapotent opioids for use in equid anesthesia.

Discuss the pros and cons of a two dart protocol in P horses.

A

A COMPARISON OF A SINGLE-DART VERSUS STAGED TWO-DART ANESTHESIA INDUCTION PROTOCOL IN PRZEWALSKI’S HORSES (EQUUS FERUS PRZEWALSKII)

JZWM 2021 52(2) 453–459

Abstract: Przewalski’s horses (Equus ferus przewalskii) are an endangered equid species. Anesthesia administered by remote delivery is often needed to provide medical care. Behavioral and physiologic parameters were prospectively compared in 14 horses (8 females and 6 males, 3–18 yr) after a single-dart or staged two-dart anesthesia induction protocol with intramuscular medetomidine (0.06 mg/kg), butorphanol (0.05 mg/kg), thiafentanil (0.02 mg/kg), and ketamine (1 mg/kg). Seven horses were randomly assigned to receive all drugs in a single dart, and the other seven to receive medetomidine and butorphanol 10 min prior to thiafentanil and ketamine in a second dart. Induction and recovery quality were scored on a scale from 1 to 5 (worst to best), and video recordings were assessed for frequency of specific behaviors. Need for supplemental propofol was recorded. Median induction score was significantly better (P = 0.01) after two darts (4/5) compared to a single dart (3/5). Degree of muscle fasciculation (undesirable) during induction was significantly lower (P = 0.006) with the two-dart protocol. During the transition to recumbency, 71% versus 14% of horses transitioned headfirst (undesirable) after a single dart versus two darts, respectively (P = 0.07). Supplemental propofol administration was necessary in 43% of horses after two darts and in 100% of horses after a single dart (P = 0.10) to facilitate intubation and reach a working depth of anesthesia. Physiologic and recovery parameters were not significantly different between groups. Improved induction quality was observed clinically using a staged two-dart versus a single-dart protocol and should be considered when anesthetizing captive Przewalski’s horses using this drug combination.

Summary:

Intro:

  • Wild equid anesthesia – challenging
    • non-opioid-based anesthesia techniques have been studied in Przewalski’s horses
    • most common - alpha-2 agonist medetomidine (sedation, muscle relaxation) with dissociative anesthetic ketamine
      • not all horses successfully immobilized with this combo
    • ultrapotent opioid-based techniques reported to induce anesthesia more reliably
      • etorphine considered opioid of choice for anesthesia in non-domestic equids
      • carfentanil - recently unavailable in US
        • rough inductions, increased muscle contraction, significant hypertension in equids
      • thiafentanil – newer, info in Przewalski’s horses limited
        • respiratory depression
          • butorphanol (antagonist of mu opioid receptor) helps mitigate

· Objective: study assessed use of thiafentanil as part of a multidrug protocol including medetomidine, butorphanol, and ketamine for anesthesia induction and influence on anesthesia quality following admin of these medications using a single-dart versus a staged two-dart induction protocol

M+M:

· effectiveness and anesthesia quality following single-dart vs staged two-dart anesthesia protocol compared in 14 captive adult Przewalski’s horses

· Drug combo for all horses: butorphanol (0.05 mg/kg), medetomidine (0.06 mg/kg), thiafentanil (0.02 mg/kg), and ketamine (1 mg/kg) IM

· single-dart protocol - all drugs in single dart

· staged two-dart protocol - medetomidine + butorphanol in 1st dart, thiafentanil + ketamine 10 min later in 2nd dart

· supplemental propofol as needed for intubation, etc

· reversal with naltrexone and atipamezole

Results/discussion:

· recumbency achieved in all horses

· induction time longer for two dart protocol

· median time to recumbency of 6 min for single-dart protocol and 15 min for two-dart protocol

· behavioral response to second dart significantly reduced because of sedative effects of first dart

· significant improvement in induction quality with staged two-dart vs single-dart protocol:

· decreased muscle fasciculation, rigidity, incoordination, and reduction in frequency of undesirable (head-first) transitions to recumbency

· when all drugs combined in single dart, first effects are largely those of thiafentanil, as opposed to those of medetomidine combined with butorphanol

· need for supplemental propofol to reach a working depth of anesthesia once recumbent not significantly different between groups

· all horses in single dart group needed propofol supplementation

· physiologic parameters not different between groups

· no significant anesthetic or postanesthetic complications noted in either group

· no difference in recovery scores – all had good to excellent recoveries

· two-dart protocol resulted in longer duration between first dart and reversal

· median duration from first dart to standing was same in both protocols

· time from reversal to standing was shorter with two-dart protocol

Conclusion: study supports use of thiafentanil in combo with butorphanol, medetomidine, and ketamine for anesthesia in Przewalski’s horses and administration of medetomidine and butorphanol prior to thiafentanil administration consistently provided improved sedation and muscle relaxation and minimized negative characteristics associated with potent opioid inductions and need for supplemental propofol; use of staged two-dart protocol provided improvements to anesthesia induction quality and may improve safety of anesthesia in Przewalski’s horses

43
Q

A recent study compared DEA & KBAM protocols for anesthesia in Przewalksi’s horses.

What is the scientific name of this species?

What are some of the adverse effects of ultrapotent opioids?

What are some of the adverse effects of BAM?

Compare and contrast the two immobilization protocols:
- What doses were used for each?
- How did induction time differ?
- How did induction quality & behaviors differ?
- What physiologic effects were seen with DEA?
- What physiologic effects were seen with KBAM?
- What physiologic effects were seen in both protocols?

A

A randomized clinical trial to compare ketamine-butorphanol-azaperone-medetomidine and detomidine-etorphine-acepromazine for anesthesia of captive Przewalski horses (Equus przewalskii).
Milnes EL, Skelding AM, Larouche CB, Ferro A, Delnatte P, Dutton C, Anderson NE.
American Journal of Veterinary Research. 2022;83(6):online

OBJECTIVE To compare ketamine-butorphanol-azaperone-medetomidine (KBAM) to detomidine-etorphine-acepromazine (DEA) for field anesthesia in captive Przewalski horses (Equus przewalskii).
ANIMALS 10 adult Przewalski horses.
PROCEDURES A prospective randomized crossover trial was conducted. Each horse was immobilized once with KBAM (200 mg ketamine, 109.2 mg butorphanol, 36.4 mg azaperone, and 43.6 mg medetomidine) and once with DEA (40 mg detomidine premedication, followed 20 minutes later by 3.9 to 4.4 mg etorphine and 16 to 18 mg acepromazine). Both protocols were administered by IM remote dart injection with a washout period of 6 months between treatments. Selected cardiorespiratory variables and quality of anesthesia were recorded. Antagonists were administered IM (KBAM, 215 mg atipamezole and 50 mg naltrexone; DEA, 4 mg RX821002 and 100 mg naltrexone).
RESULTS All horses were anesthetized and recovered uneventfully. Inductions (DEA, 6.8 min; KBAM, 11.6 min; P = 0.04) and recoveries (DEA, 3.2 min; KBAM, 19.6 min; P < 0.01) were faster with DEA compared with KBAM. Quality scores for induction and recovery did not differ between protocols, but maintenance quality was poorer for DEA (P < 0.01). Clinical concerns during DEA immobilizations included apnea, severe hypoxemia (arterial partial pressure of oxygen < 60 mm Hg), muscle rigidity, and tremors. Horses treated with KBAM were moderately hypoxemic, but arterial partial pressures of oxygen were higher compared with DEA (P < 0.01).
CLINICAL RELEVANCE Captive Przewalski horses are effectively immobilized with KBAM, and this protocol results in superior muscle relaxation and less marked hypoxemia during the maintenance phase, but slower inductions and recoveries, compared with DEA.

Background
- Przewalski horse - endangered, extinct in the wild mid-1960’s, successfully reintroduced into parts of its former range
– Typical protocol (wild and captive): etorphine, butorphanol, detomidine or 2 step detomidine IM followed by etorphine-acepromazine IM
- AE of UPO: respiratory depression, hypertension, muscle tremors, renarcotization, human exposure
- AE of BAM in nondomestic ungulates: prolonged induction, hypoxemia
– IV atipamezole can cause excitement and profound vasodilation with hypotension

Key Points
- DEA: Detomidine (0.13 mg/kg), Etorphine/Acepromazine combo drug (E 0.013 mg/kg, A 0.05 mg/kg)
– Reversed with RX821002 compounded 0.1:1 (for detomidine), naltrexone 20:1
– By 20 min all at moderate standing sedation, minimal response to etorphine dart
– Induction - most stood still with head down or pressed against wall, muscle tremors before falling into lateral recumbency
– One animal in each group required supplemental drugs to go down
– Most - severe muscle rigidity, tremors, spontaneous limb movements during maintenance, one spontaneously stood up and required ketamine
– HR faster, more variable, resp rates slower than KBAM; apnea of 20+ sec in 6/8 but not seen with KBAM, higher rectal temps but WNL
– Most horses had mod-severe hypoxemia, worse with DEA; all normocapnic and normal pH; DEA higher PaCO2, HCO2, BE, lower pH but WNL
- KBAM: Ketamine (0.66 mg/kg), BAM (B 0.36 mg/kg, A 0.12 mg/kg, M 0.14 mg/kg)
– Reversed with atipamezole 5:1, naltrexone 0.5:1 mg/kg est at 300 kg horse
– 2 pregnant mares at 12 wks, subsequently birthed live foals at term
– Slower mean induction time (11 min vs 7 min DEA), no difference in induction quality
– Moderate to severe ataxia during induction, penile prolapse seen with DEA that persisted during recovery, resolved within 6 hr, no complications
– Smooth and relaxed maintenance
– Slower mean recovery time, similar recovery quality scores, both groups stood on first attempt
– No renarcotization, morbidity, or death

Conclusions
- KBAM may provide a useful alternative to etorphine-based combos for captive Przewalski horses due to subjectively better immobilization quality compared to apnea and severe muscle tremors/rigidity with DEA.
- However KBAM induction and recovery periods were longer and less predictable and could increase risk of injury caused by ataxia
- Low PaO2 (KBAM) to severe hypoxemia (DEA) occurred in both protocols, O2 supplementation is recommended